Taysha Gene Therapies
TSHA
#6714
Rank
HK$3.81 B
Marketcap
HK$18.59
Share price
46.63%
Change (1 day)
78.97%
Change (1 year)

P/S ratio for Taysha Gene Therapies (TSHA)

P/S ratio as of November 2024 (TTM): 38.0

According to Taysha Gene Therapies's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 4.50. At the end of 2024 the company had a P/S ratio of 35.0.

P/S ratio history for Taysha Gene Therapies from 2020 to 2024

PS ratio at the end of each year

Year P/S ratio Change
202435.063.61%
202321.4-62.03%
202256.4
2021N/A
2020N/A

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA